Look at headline CPI and PCE to understand broad direction. Then pay attention to components that matter most to your ...

SpyGlass Pharma has released positive data from 2 trials of its lead candidate, the Bimatoprost Drug Pad-IOL System (BIM-IOL ...

So OpenAI may not be special, but AI still is. The U.S. is all-in on datacenter build-outs. AI’s massive power demands, ...

A novel once-daily oral PCSK9 inhibitor lowered LDL by up to 60% at 24 weeks in patients with heart disease or at high risk ...

When the news and PR sectors intersect to the degree that they do in Ireland, it becomes fair to ask whose interests the news ...

The novel, oral interleukin-23 inhibitor icotrokinra bested placebo in multiple skin outcomes among adolescent patients with ...

Household income is a sensitive subject for many. If you're starting to make your own money, see how you stack up to learn if you're above or below average.

Elafibranor (Iqirvo) was well tolerated and led to sustained improvements in liver enzyme levels and itch severity through 28 weeks in patients with primary sclerosing cholangitis (PSC), according to ...

The world is sitting back waiting, not-so-patiently, to see what the Federal Reserve, led by Jerome Powell, decides to do ...

The youth social media ban has made headlines, but an arguably bigger change to the way Australians use the internet comes ...

KUT's Miles Bloxson and Elizabeth McQueen explore how Austin musicians are adapting to AI and the changing music industry.

For Medicaid care management, focusing on rising-risk patients is more effective than targeting high-cost claimants, whose spending tends to decrease over time due to regression to the mean.